10-K Filing

XILIO THERAPEUTICS, INC. CIK: 1840233 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001558370-23-002687`
Period End Date	20221231
Filing Date	20230302
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	xlo-20221231x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 24 Cash Flow Statement 53 Stockholders Equity 16

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$198.05M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.39M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.11M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.46M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$124.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$202.52M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.55M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.56M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.62M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.36M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.43M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.25M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.58M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.98M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$393.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$267.00K	USD	Point-in-time
Total assets	`Assets`	$218.06M	USD	Point-in-time
Total assets	`Assets`	$139.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.12M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.14M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.33M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.75M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$801.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$918.00K	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$6.67M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.12M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$3.17M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$9.63M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$10.11M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$9.19M	USD	Point-in-time
Other liabilities, long-term	`OtherLiabilitiesNoncurrent`	$118.00K	USD	Point-in-time
Other liabilities, long-term	`OtherLiabilitiesNoncurrent`	$45.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$33.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$32.63M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at December 31, 2022 and December 31, 2021, no shares issued or outstanding at December 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at December 31, 2022 and December 31, 2021, no shares issued or outstanding at December 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at December 31, 2022 and December 31, 2021; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022; 27,468,950 shares issued and 27,358,375 shares outstanding at December 31, 2021	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at December 31, 2022 and December 31, 2021; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022; 27,468,950 shares issued and 27,358,375 shares outstanding at December 31, 2021	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$346.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$354.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-160.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-249.11M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$105.65M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$185.43M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$218.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$139.16M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$51.19M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$59.20M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$23.86M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$29.95M	USD	Annual
Total operating expenses	`OperatingExpenses`	$75.04M	USD	Annual
Total operating expenses	`OperatingExpenses`	$89.15M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-89.15M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-75.04M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$927.00K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-756.00K	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$927.00K	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-756.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-75.80M	USD	Annual
Net loss	`NetIncomeLoss`	$-88.22M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-88.22M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-75.80M	USD	Annual
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-13.52	USD	Annual
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-3.22	USD	Annual
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-13.52	USD	Annual
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-3.22	USD	Annual
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.61M	shares	Annual
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.39M	shares	Annual
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	5.61M	shares	Annual
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.39M	shares	Annual

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-88.22M	USD	Annual
Net loss	`ProfitLoss`	$-75.80M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.50M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.85M	USD	Annual
Non-cash interest expense	`NoncashInterestExpense`	$173.00K	USD	Annual
Non-cash interest expense	`NoncashInterestExpense`	$223.00K	USD	Annual
Equity-based compensation expense	`ShareBasedCompensation`	$4.96M	USD	Annual
Equity-based compensation expense	`ShareBasedCompensation`	$8.42M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-1.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-19.00K	USD	Annual
Change in fair value of warrant and derivative liabilities	`FairValueAdjustmentsOfWarrantsAndDerivativeLiabilities`	$203.00K	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.14M	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-344.00K	USD	Annual
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-332.00K	USD	Annual
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-391.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.82M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$485.00K	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.58M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-5.62M	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-801.00K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-564.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-75.72M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-80.75M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.10M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.87M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.10M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.87M	USD	Annual
Repayments of debt principal	`RepaymentsOfDebt`	$1.00M	USD	Annual
Proceeds from debt issuance, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$975.00K	USD	Annual
Payments of finance lease	`FinanceLeasePrincipalPayments`	$85.00K	USD	Annual
Payments of finance lease	`FinanceLeasePrincipalPayments`	$85.00K	USD	Annual
Payments of success fee	`PaymentForSuccessFeesFinancingActivities`	$750.00K	USD	Annual
Proceeds from issuance of convertible preferred stock, net of issuance costs	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$144.89M	USD	Annual
Proceeds from initial public offering, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$116.36M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$16.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$283.00K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-69.00K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$260.67M	USD	Annual
(Decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-77.66M	USD	Annual
(Decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$178.82M	USD	Annual
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.79M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.79M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$492.00K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$555.00K	USD	Annual
Conversion of convertible preferred stock into common stock upon initial public offering	`ConversionOfStockAmountIssued1`	$222.89M	USD	Annual
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$539.00K	USD	Annual
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$19.00K	USD	Annual
Recognition of derivative liability in connection with long-term debt facility	`DerivativeLiabilityRecognized`	$250.00K	USD	Annual
Conversion of warrant liability to equity upon initial public offering	`ConversionOfWarrantsIntoEquity`	$28.00K	USD	Annual

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Conversion of convertible preferred stock into common stock upon initial public offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$222.89M	USD	Annual
Issuance of common stock upon initial public offering, net of issuance costs of $13,547	`StockIssuedDuringPeriodValueNewIssues`	$116.36M	USD	Annual
Conversion of warrant liability to equity upon initial public offering	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$28.00K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$283.00K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	Annual
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2,657.00	shares	Annual
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$8.42M	USD	Annual
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-75.80M	USD	Annual
Net loss	`NetIncomeLoss`	$-88.22M	USD	Annual
Ending balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-83.29M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.